Literature DB >> 22747945

Reversal of the extreme coenzyme selectivity of Clostridium symbiosum glutamate dehydrogenase.

Michael A Sharkey1, Alessandro Gori, Marina Capone, Paul C Engel.   

Abstract

Active-site mutants of glutamate dehydrogenase from Clostridium symbiosum have been designed and constructed and the effects on coenzyme preference evaluated by detailed kinetic measurements. The triple mutant F238S/P262S/D263K shows complete reversal in coenzyme selectivity from NAD(H) to NADP(H) with retention of high levels of catalytic activity for the new coenzyme. For oxidized coenzymes, k(cat) /K(m) ratios of the wild-type and triple mutant enzyme indicate a shift in preference of approximately 1.6 × 10(7) -fold, from ∼ 80,000-fold in favour of NAD(+) to ∼ 200-fold in favour of NADP(+). For reduced coenzymes the corresponding figure is 1.7 × 10(4) -fold, from ∼ 1000-fold in favour of NADH to ∼ 17-fold in favour of NADPH. A fourth mutation (N290G), previously identified as having a potential bearing on coenzyme specificity, did not engender any further shift in preference when incorporated into the triple mutant, despite having a significant effect when expressed as a single mutant.
© 2012 The Authors Journal compilation © 2012 FEBS.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22747945     DOI: 10.1111/j.1742-4658.2012.08681.x

Source DB:  PubMed          Journal:  FEBS J        ISSN: 1742-464X            Impact factor:   5.542


  3 in total

1.  Conservation of the Enzyme-Coenzyme Interfaces in FAD and NADP Binding Adrenodoxin Reductase-A Ubiquitous Enzyme.

Authors:  Israel Hanukoglu
Journal:  J Mol Evol       Date:  2017-11-24       Impact factor: 2.395

Review 2.  Glutamate dehydrogenases: the why and how of coenzyme specificity.

Authors:  Paul C Engel
Journal:  Neurochem Res       Date:  2013-06-13       Impact factor: 3.996

Review 3.  Protein Engineering for Nicotinamide Coenzyme Specificity in Oxidoreductases: Attempts and Challenges.

Authors:  Andrea M Chánique; Loreto P Parra
Journal:  Front Microbiol       Date:  2018-02-14       Impact factor: 5.640

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.